Scholar Rock Holding (SRRK) Operating Expenses (2017 - 2026)
Scholar Rock Holding's (SRRK) quarterly Operating Expenses came in at $102.0 million in Q1 2026, up 32.33% year-on-year from $77.1 million in Q1 2025, and up 11.01% quarter-over-quarter from $91.9 million in Q4 2025.
Scholar Rock Holding (SRRK) Operating Expenses (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Operating Expenses history runs 10 years deep, the most recent figure standing at $102.0 million for Q1 2026.
- On a quarterly basis, Operating Expenses rose 32.33% year-over-year to $102.0 million in Q1 2026; TTM through Mar 2026 was $409.6 million, a 51.29% increase from a year earlier, with the FY2025 full-year figure at $384.6 million, up 52.6% from the prior year.
- Operating Expenses rose to $102.0 million in Q1 2026 per SRRK's latest filing, from $91.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $112.1 million in Q2 2025 and bottomed at $39.1 million in Q2 2023.
- The 5-year median for Operating Expenses is $58.4 million (2024), against an average of $63.4 million.
- Across the five-year window, Operating Expenses fell 9.42% in 2023 and jumped 88.42% in 2025, its largest moves.
- Year by year, Operating Expenses stood at $40.4 million in 2022, then advanced by 18.81% to $48.0 million in 2023, then surged by 44.4% to $69.4 million in 2024, then surged by 32.5% to $91.9 million in 2025, then climbed by 11.01% to $102.0 million in 2026.
- Per Business Quant, the three latest SRRK Operating Expenses figures stand at $102.0 million (Q1 2026), $91.9 million (Q4 2025), and $103.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - | 102.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.02 Mn |
| Dec 31, 2025 | 91.90 Mn |
| Sep 30, 2025 | 103.55 Mn |
| Jun 30, 2025 | 112.11 Mn |
| Mar 31, 2025 | 77.09 Mn |
| Dec 31, 2024 | 69.36 Mn |
| Sep 30, 2024 | 64.78 Mn |
| Jun 30, 2024 | 59.50 Mn |
| Mar 31, 2024 | 58.42 Mn |
| Dec 31, 2023 | 48.03 Mn |
| Sep 30, 2023 | 43.67 Mn |
| Jun 30, 2023 | 39.08 Mn |
| Mar 31, 2023 | 40.51 Mn |
| Dec 31, 2022 | 40.43 Mn |
| Sep 30, 2022 | 43.86 Mn |
| Jun 30, 2022 | 43.15 Mn |
| Mar 31, 2022 | 40.13 Mn |
| Dec 31, 2021 | 39.41 Mn |
| Sep 30, 2021 | 42.54 Mn |
| Jun 30, 2021 | 34.87 Mn |